|
1
|
World Health Organization. GLOBOCAN 2012:
Estimated Cancer Incidence, Mortality and Prevalence Worldwide in
2012. http://globocan.iarc.fr/Pages/fact_sheets_population.aspx.
Accessed May 8, 2014
|
|
2
|
Blum HE: Hepatocellular carcinoma: therapy
and prevention. World J Gastroenterol. 11:7391–7400. 2005.
|
|
3
|
Yan JW, Lin JS and He XX: The emerging
role of miR-375 in cancer. Int J Cancer. 135:1011–1018. 2014.
View Article : Google Scholar
|
|
4
|
Ladeiro Y, Couchy G, Balabaud C, et al:
MicroRNA profiling in hepatocellular tumors is associated with
clinical features and oncogene/tumor suppressor gene mutations.
Hepatology. 47:1955–1963. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gong J, Zhang JP, Li B, et al:
MicroRNA-125b promotes apoptosis by regulating the expression of
Mcl-1, Bcl-w and IL-6R. Oncogene. 32:3071–3079. 2013. View Article : Google Scholar
|
|
6
|
Vasudevan S, Tong Y and Steitz JA:
Switching from repression to activation: microRNAs can up-regulate
translation. Science. 318:1931–1934. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Henke JI, Goergen D, Zheng J, et al:
microRNA-122 stimulates translation of hepatitis C virus RNA. EMBO
J. 27:3300–3310. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shimakami T, Yamane D, Jangra RK, et al:
Stabilization of hepatitis C virus RNA by an Ago2-miR-122 complex.
Proc Natl Acad Sci USA. 109:941–946. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tsai NP, Lin YL and Wei LN: MicroRNA
mir-346 targets the 5′-untranslated region of receptor-interacting
protein 140 (RIP140) mRNA and up-regulates its protein expression.
Biochem J. 424:411–418. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Krol J, Loedige I and Filipowicz W: The
widespread regulation of microRNA biogenesis, function and decay.
Nat Rev Genet. 11:597–610. 2010.PubMed/NCBI
|
|
11
|
Lu J, Getz G, Miska EA, et al: MicroRNA
expression profiles classify human cancers. Nature. 435:834–838.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Murakami Y, Yasuda T, Saigo K, et al:
Comprehensive analysis of microRNA expression patterns in
hepatocellular carcinoma and non-tumorous tissues. Oncogene.
25:2537–2545. 2006. View Article : Google Scholar
|
|
13
|
Ji J, Yamashita T, Budhu A, et al:
Identification of microRNA-181 by genome-wide screening as a
critical player in EpCAM-positive hepatic cancer stem cells.
Hepatology. 50:472–480. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Budhu A, Jia HL, Forgues M, et al:
Identification of metastasis-related microRNAs in hepatocellular
carcinoma. Hepatology. 47:897–907. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ji J, Shi J, Budhu A, et al: MicroRNA
expression, survival, and response to interferon in liver cancer. N
Engl J Med. 361:1437–1447. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mizuguchi Y, Mishima T, Yokomuro S, et al:
Sequencing and bioinformatics-based analyses of the microRNA
transcriptome in hepatitis B-related hepatocellular carcinoma. PloS
One. 6:e153042011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li Q, Wang G, Shan JL, et al: MicroRNA-224
is upregulated in HepG2 cells and involved in cellular migration
and invasion. J Gastroenterol Hepatol. 25:164–171. 2010. View Article : Google Scholar
|
|
18
|
Coulouarn C, Factor VM, Andersen JB,
Durkin ME and Thorgeirsson SS: Loss of miR-122 expression in liver
cancer correlates with suppression of the hepatic phenotype and
gain of metastatic properties. Oncogene. 28:3526–3536. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang XH, Wang Q, Chen JS, et al:
Bead-based microarray analysis of microRNA expression in
hepatocellular carcinoma: miR-338 is downregulated. Hepatol Res.
39:786–794. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wong QW, Lung RW, Law PT, et al:
MicroRNA-223 is commonly repressed in hepatocellular carcinoma and
potentiates expression of Stathmin1. Gastroenterology. 135:257–269.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Papaconstantinou I, Karakatsanis A,
Gazouli M, Polymeneas G and Voros D: The role of microRNAs in liver
cancer. Eur J Gastroenterol Hepatol. 24:223–228. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang Y, Lee AT, Ma JZ, et al: Profiling
microRNA expression in hepatocellular carcinoma reveals
microRNA-224 up-regulation and apoptosis inhibitor-5 as a
microRNA-224-specific target. J Biol Chem. 283:13205–13215. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Varnholt H: The role of microRNAs in
primary liver cancer. Ann Hepatol. 7:104–113. 2008.PubMed/NCBI
|
|
24
|
Wong QW, Ching AK, Chan AW, et al: MiR-222
overexpression confers cell migratory advantages in hepatocellular
carcinoma through enhancing AKT signaling. Clin Cancer Res.
16:867–875. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fu X, Meng Z, Liang W, et al: miR-26a
enhances miRNA biogenesis by targeting Lin28B and Zcchc11 to
suppress tumor growth and metastasis. Oncogene. 33:4296–4306. 2014.
View Article : Google Scholar
|
|
26
|
Chen L, Zheng J, Zhang Y, et al:
Tumor-specific expression of microRNA-26a suppresses human
hepatocellular carcinoma growth via cyclin-dependent and
-independent pathways. Mol Ther. 19:1521–1528. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ho CM, Lee PH and Hu RH: Clinical
correlation of miR-375 and alpha-fetoprotein in hepatocellular
carcinoma: comparison in mice and humans. Hepatology. 54:1105–1106.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kim JK, Noh JH, Jung KH, et al: Sirtuin7
oncogenic potential in human hepatocellular carcinoma and its
regulation by the tumor suppressors MiR-125a-5p and MiR-125b.
Hepatology. 57:1055–1067. 2013. View Article : Google Scholar
|
|
29
|
Liang L, Wong CM, Ying Q, et al:
MicroRNA-125b suppresses human liver cancer cell proliferation and
metastasis by directly targeting oncogene LIN28B2. Hepatology.
52:1731–1740. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li LM, Hu ZB, Zhou ZX, et al: Serum
microRNA profiles serve as novel biomarkers for HBV infection and
diagnosis of HBV-positive hepatocarcinoma. Cancer Res.
70:9798–9807. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Furuta M, Kozaki KI, Tanaka S, Arii S,
Imoto I and Inazawa J: miR-124 and miR-203 are epigenetically
silenced tumor-suppressive microRNAs in hepatocellular carcinoma.
Carcinogenesis. 31:766–776. 2010. View Article : Google Scholar
|
|
32
|
Liu AM, Poon RT and Luk JM: MicroRNA-375
targets Hippo-signaling effector YAP in liver cancer and inhibits
tumor properties. Biochem Biophys Res Commun. 394:623–627. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pineau P, Volinia S, McJunkin K, et al:
miR-221 overexpression contributes to liver tumorigenesis. Proc
Natl Acad Sci USA. 107:264–269. 2010. View Article : Google Scholar :
|
|
34
|
Meng F, Henson R, Wehbe-Janek H, Ghoshal
K, Jacob ST and Patel T: MicroRNA-21 regulates expression of the
PTEN tumor suppressor gene in human hepatocellular cancer.
Gastroenterology. 133:647–658. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Callegari E, Elamin BK, Giannone F, et al:
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic
model. Hepatology. 56:1025–1033. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fornari F, Gramantieri L, Ferracin M, et
al: MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human
hepatocellular carcinoma. Oncogene. 27:5651–5661. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Garofalo M, Di Leva G, Romano G, et al:
miR-221&222 regulate TRAIL resistance and enhance
tumorigenicity through PTEN and TIMP3 downregulation. Cancer Cell.
16:498–509. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gramantieri L, Fornari F, Ferracin M, et
al: MicroRNA-221 targets Bmf in hepatocellular carcinoma and
correlates with tumor multifocality. Clin Cancer Res. 15:5073–5081.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Li Q, Ding C, Chen C, et al: miR-224
promotion of cell migration and invasion by targeting Homeobox D 10
gene in human hepatocellular carcinoma. J Gastroenterol Hepatol.
29:835–842. 2014. View Article : Google Scholar
|
|
40
|
Scisciani C, Vossio S, Guerrieri F, et al:
Transcriptional regulation of miR-224 upregulated in human HCCs by
NFκB inflammatory pathways. J Hepatol. 56:855–861. 2012. View Article : Google Scholar
|
|
41
|
Yao G, Yin M, Lian J, et al: MicroRNA-224
is involved in transforming growth factor-beta-mediated mouse
granulosa cell proliferation and granulosa cell function by
targeting Smad4. Mol Endocrinol. 24:540–551. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Qiu X, Dong S, Qiao F, et al: HBx-mediated
miR-21 upregulation represses tumor-suppressor function of PDCD4 in
hepatocellular carcinoma. Oncogene. 32:3296–3305. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhou L, Yang ZX, Song WJ, et al:
MicroRNA-21 regulates the migration and invasion of a stem-like
population in hepatocellular carcinoma. Int J Oncol. 43:661–669.
2013.PubMed/NCBI
|
|
44
|
Xu G, Zhang Y, Wei J, et al: MicroRNA-21
promotes hepatocellular carcinoma HepG2 cell proliferation through
repression of mitogen-activated protein kinase-kinase 3. BMC
Cancer. 13:4692013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kutay H, Bai S, Datta J, et al:
Downregulation of miR-122 in the rodent and human hepatocellular
carcinomas. J Cell Biochem. 99:671–678. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Gramantieri L, Ferracin M, Fornari F, et
al: Cyclin G1 is a target of miR-122a, a microRNA frequently
down-regulated in human hepatocellular carcinoma. Cancer Res.
67:6092–6099. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Jung CJ, Iyengar S, Blahnik KR, et al:
Epigenetic modulation of miR-122 facilitates human embryonic stem
cell self-renewal and hepatocellular carcinoma proliferation. PloS
One. 6:e277402011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Bai S, Nasser MW, Wang B, et al:
MicroRNA-122 inhibits tumorigenic properties of hepatocellular
carcinoma cells and sensitizes these cells to sorafenib. J Biol
Chem. 284:32015–32027. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
He XX, Chang Y, Meng FY, et al:
MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and
suppresses liver cancer cell growth in vitro and in vivo. Oncogene.
31:3357–3369. 2012. View Article : Google Scholar
|
|
50
|
Chang Y, Yan W, He X, et al: miR-375
inhibits autophagy and reduces viability of hepatocellular
carcinoma cells under hypoxic conditions. Gastroenterology.
143:177–187. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Kota J, Chivukula RR, O’Donnell KA, et al:
Therapeutic microRNA delivery suppresses tumorigenesis in a murine
liver cancer model. Cell. 137:1005–1017. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Yang X, Liang L, Zhang XF, et al:
MicroRNA-26a suppresses tumor growth and metastasis of human
hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway.
Hepatology. 58:158–170. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Yang X, Zhang XF, Lu X, et al:
MicroRNA-26a suppresses angiogenesis in human hepatocellular
carcinoma by targeting hepatocyte growth factor-cMet pathway.
Hepatology. 59:1874–1885. 2014. View Article : Google Scholar
|
|
54
|
Moeini A, Cornellà H and Villanueva A:
Emerging signaling pathways in hepatocellular carcinoma. Liver
Cancer. 1:83–93. 2012. View Article : Google Scholar
|
|
55
|
Joyce JA and Pollard JW:
Microenvironmental regulation of metastasis. Nat Rev Cancer.
9:239–252. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Hatziapostolou M, Polytarchou C, Aggelidou
E, et al: An HNF4α-miRNA inflammatory feedback circuit regulates
hepatocellular oncogenesis. Cell. 147:1233–1247. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Yan XL, Jia YL, Chen L, et al:
Hepatocellular carcinoma-associated mesenchymal stem cells promote
hepatocarcinoma progression: role of the S100A4-miR155-SOCS1-MMP9
axis. Hepatology. 57:2274–2286. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Yang CH, Yue J, Fan M and Pfeffer LM: IFN
induces miR-21 through a signal transducer and activator of
transcription 3-dependent pathway as a suppressive negative
feedback on IFN-induced apoptosis. Cancer Res. 70:8108–8116. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Haghikia A, Hoch M, Stapel B and
Hilfiker-Kleiner D: STAT3 regulation of and by microRNAs in
development and disease. JAKSTAT. 1:143–150. 2012.PubMed/NCBI
|
|
60
|
Sun BS, Dong QZ, Ye QH, et al:
Lentiviral-mediated miRNA against osteopontin suppresses tumor
growth and metastasis of human hepatocellular carcinoma.
Hepatology. 48:1834–1842. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Haybaeck J, Zeller N, Wolf MJ, et al: A
lymphotoxin-driven pathway to hepatocellular carcinoma. Cancer
Cell. 16:295–308. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Zhang X, Liu S, Hu T, Liu S, He Y and Sun
S: Up-regulated microRNA-143 transcribed by nuclear factor kappa B
enhances hepatocarcinoma metastasis by repressing fibronectin
expression. Hepatology. 50:490–499. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Wang B, Majumder S, Nuovo G, et al: Role
of microRNA-155 at early stages of hepatocarcinogenesis induced by
choline-deficient and amino acid-defined diet in C57BL/6 mice.
Hepatology. 50:1152–1161. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Iliopoulos D, Hirsch HA and Struhl K: An
epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and
IL6 links inflammation to cell transformation. Cell. 139:693–706.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Wang L, Zhang X, Jia LT, et al:
c-Myc-mediated epigenetic silencing of MicroRNA-101 contributes to
dysregulation of multiple pathways in hepatocellular carcinoma.
Hepatology. 59:1850–1863. 2014. View Article : Google Scholar
|
|
66
|
Wei R, Huang GL, Zhang MY, et al: Clinical
significance and prognostic value of microRNA expression signatures
in hepatocellular carcinoma. Clin Cancer Res. 19:4780–4791. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Tomimaru Y, Eguchi H, Nagano H, et al:
Circulating microRNA-21 as a novel biomarker for hepatocellular
carcinoma. J Hepatol. 56:167–175. 2012. View Article : Google Scholar
|
|
68
|
Qi J, Wang J, Katayama H, Sen S and Liu
SM: Circulating microRNAs (cmiRNAs) as novel potential biomarkers
for hepatocellular carcinoma. Neoplasma. 60:135–142. 2013.
View Article : Google Scholar :
|
|
69
|
Köberle V, Kronenberger B, Pleli T, et al:
Serum microRNA-1 and microRNA-122 are prognostic markers in
patients with hepatocellular carcinoma. Eur J Cancer. 49:3442–3449.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Park JK, Kogure T, Nuovo GJ, et al:
miR-221 silencing blocks hepatocellular carcinoma and promotes
survival. Cancer Res. 71:7608–7616. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Ma L, Liu J, Shen J, et al: Expression of
miR-122 mediated by adenoviral vector induces apoptosis and cell
cycle arrest of cancer cells. Cancer Biol Ther. 9:554–561. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Khare S, Zhang Q and Ibdah JA: Epigenetics
of hepatocellular carcinoma: role of microRNA. World J
Gastroenterol. 19:5439–5445. 2013. View Article : Google Scholar : PubMed/NCBI
|
